Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Fund Letter | Amit WadhwaneyMoerus Capital Management LLC | -- | Moerus Capital Management LLC - TATACHEM.NS The other newly added position, Tata Chemicals Ltd., part of the Tata Group, is an Indian-domiciled chemicals company with a strong presence in the soda ash industry. Soda ash is... | NEUTRAL | View Pitch → | |
| Aug 21, 2026 | Fund Letter | Stephen E. GrantValue Line Small Cap Opportunities Fund | Chemed Corp. $CHE• NYSE | Health Care Providers & ServicesHealth Care Providers & Services | Short CHE (Chemed Corporation) Chemed was liquidated entirely during the first quarter as part of a portfolio refinement program. The manager sought... | BEAR | View Pitch → |
| Dec 3, 2025 | Fund Letter | Jack McPherson and Dave AdamsAristotle Small Cap Equity Fund | Chemed Corp. $CHE• NYSE | Health Care Providers & ServicesHealth Care Providers & Services | Aristotle Small Cap Equity Fund 2025 Q2 (CHE) Chemed (CHE), engages in the provision of healthcare and maintenance services operating through two segments: VITAS and Roto-Rooter. The VITAS segment... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.